Becton, Dickinson and Company

Becton, Dickinson and Company has been granted 2,235 US utility patents between 2015 and 2025, placing Becton, Dickinson and Company at rank #175 across all assignees tracked by PlainPatent. This portfolio spans 143 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.7 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Becton, Dickinson and Company is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 67.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1,364 grants, compared with 871 in the 2015–2019 window — a +57% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Becton, Dickinson and Company's 14.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Becton, Dickinson and Company against peers pursuing similar technology classes.